Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patientsAlexandros Spyridonidis, Mohamad Mohty, Laimonas Griškevičius et al.|Bone Marrow Transplantation|2020Cited by 202
Clinical practice recommendation on hematopoietic stem cell transplantation for acute myeloid leukemia patients with <i>FLT3</i>-internal tandem duplication: a position statement from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationAli Bazarbachi, Mohamad Mohty, Gesine Bug et al.|Haematologica|2020Cited by 137
Management of patients with acute leukemia during the COVID-19 outbreak: practical guidelines from the acute leukemia working party of the European Society for Blood and Marrow TransplantationÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Bone Marrow Transplantation|2020Cited by 74
Post-transplant cyclophosphamide versus antithymocyte globulin in patients with acute myeloid leukemia in first complete remission undergoing allogeneic stem cell transplantation from 10/10 HLA-matched unrelated donorsÉolia Brissot, Mohamad Mohty, Myriam Labopin et al.|Journal of Hematology & Oncology|2020Cited by 68
Significance of Measurable Residual Disease in Adult Philadelphia Chromosome–Positive ALL: A GRAAPH-2014 StudyRathana Kim, Emmanuelle Clappier, Yves Chalandon et al.|Journal of Clinical Oncology|2024Cited by 39